Drug-Drug Interaction: Bivalirudin interacts with Deferasirox
Drug-Drug Interaction Description: Anticoagulants increase the risk for gastrointestinal ulceration/irritation and/or GI bleeding. If these two agents must be used, patients need to be closely monitored for signs and symptoms of GI toxicity.
Drug : DB01609 Deferasirox Deferasirox ['Deferasiroxum [inn-latin]', 'ICL 670']
Drug-Drug Interaction: Bivalirudin interacts with Gemcitabine
Drug-Drug Interaction Description: Gemcitabine may enhance the adverse/toxic effect of Bleomycin. The risk of pulmonary toxicity may be increased. Use extreme caution if using gemcitabine and bleomycin in combination. Monitor for the development of pulmonary toxicity.
Drug-Drug Interaction: Bivalirudin interacts with Rivaroxaban
Drug-Drug Interaction Description: Anticoagulants may enhance the anticoagulant effect of rivaroxaban. Avoid concurrent use of rivaroxaban with other anticoagulants whenever possible, other than during transition periods, due to the possible increased for bleeding.
Drug : DB06228 Rivaroxaban Rivaroxaban ['BAY 59-7939']
Drug-Drug Interaction: Bivalirudin interacts with Treprostinil
Drug-Drug Interaction Description: The prostacyclin analogue, Treprostinil, increases the risk of bleeding when combined with the anticoagulant, Bivalirudin. Monitor for increased bleeding during concomitant thearpy.